ATLASATLAS fair value
SEK 35.81
Above fair value · 156% premium
Range: SEK 25–SEK 51Fair valuePrice
Apotea (APOTEA.ST)
Apotea stock price today, ATLAS forecast and fair value
Healthcare · Pharmaceutical Retailers · Nasdaq Stockholm · Sweden
SEK 91.55▲ +0.77%
Prices as of Oct 26, 2026 · SEK
Chance of rising in 1 month
51%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Apotea in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Apotea
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates Apotea's fair value at about SEK 35.81 per share (reasonable range: SEK 25.00 to SEK 50.78). At SEK 91.55, the stock trades 156% above it.
It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is low. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Apotea a 51% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between SEK 87.44 and SEK 96.34; in 9 out of 10, between SEK 80.25 and SEK 104.98. Estimated annual volatility is 22%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- SEK 9.1B
- Market cap (USD)
- $914M
- P/E ratio
- 37.5
- Dividend yield
- 0.67%
- 52-week high
- SEK 94.50
- 52-week low
- SEK 54.42
- Revenue (12 months)
- SEK 7.6B
- Gross margin
- 19.9%
- Operating margin
- 5.1%
- Net margin
- 3.2%
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Apotea sits above fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks APOTEA.ST has traded between SEK 54.42 and SEK 94.50. Today it is 3.1% below that high and 68% above its low.
On the business: net margin is 3.2%; it trades at 37.5 times earnings.
About the company
Apotea AB (publ) operates an online pharmacy in Sweden.
Want to see everything about Apotea?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is Apotea (APOTEA.ST) fair value?
About SEK 35.81 per share according to ATLAS (reasonable range: SEK 25.00 to SEK 50.78). With the stock at SEK 91.55, it is 156% above it.
What is the chance APOTEA.ST goes up next month?
51%: close to a coin flip. In half of the simulated outcomes, APOTEA.ST ends the month between SEK 87.44 and SEK 96.34.
How big is Apotea and what is its P/E ratio?
Apotea's market capitalization is SEK 9.1B. Its price-to-earnings (P/E) ratio is 37.5: you pay SEK 37.5 for each SEK 1.00 of yearly earnings.
Does Apotea pay a dividend?
Yes. APOTEA.ST's current dividend yield is 0.67% at today's price (SEK 91.55).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer